CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale CEO sold 50,000 shares at an average $28.87 ($1,443,528)
- 4 Derivatives Options or other derivatives
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale SVP, Finance and Treasurer sold 6,198 shares at $35.00 ($216,933)
- 4 Planned sale Chief Legal Officer sold 1,371 shares at $34.00 ($46,614)
- 144 Insider Sale of Securities
- 4 Planned sale SVP, Finance and Treasurer sold 3,034 shares at $30.12 ($91,384)
- 4 Planned sale Chief Legal Officer sold 18,629 shares at an average $34.61 ($644,832)
- 144 Insider Sale of Securities
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Planned sale Chief Financial Officer sold 6,294 shares at $27.10 ($170,567)
- 4 Planned sale Chief Legal Officer sold 1,254 shares at $27.10 ($33,983)
Page 4 of 26 · 514 filings